Chaoju Eye Care Holdings Limited (2219) announced an intention to repurchase shares on the open market, with a current aggregate purchase limit of up to HK$50 million. According to the announcement, the repurchase may begin on 17 November 2025 and will be conducted under the existing Share Repurchase Mandate approved at the annual general meeting on 6 June 2025.

The company stated that the repurchase’s timing and amount will depend on market conditions, and the maximum aggregate purchase limit may be increased. The announcement clarified that there is no guarantee regarding the timing, quantity, or price of any share repurchases, and investors are advised to exercise caution when dealing in the company’s shares.